MultiCare Capital Medical Center
3900 Capital Mall DR SW, Olympia, WA · Multicare · · NPI 1841258639
Published prices by procedure
Cash price is what you pay without insurance. The negotiated range spans the lowest to highest rate this hospital agreed with insurers.
| Procedure | Cash price | Gross charge | Negotiated range | Payers |
|---|---|---|---|---|
| Inject/treat eye socket CPT 67505 | not published | not published | $235.32 – $1,642.15 | 15 |
| Inject/treat eye socket CPT 67515 | not published | not published | $235.32 – $1,642.15 | 15 |
| Inj, eculizumab-aagh, 2 mg HCPCS Q5151 | not published | not published | $31.29 – $57.89 | 8 |
| Inj, eculizumab-aeeb, 2 mg HCPCS Q5152 | not published | not published | $40.95 – $75.76 | 8 |
| Inj efgart-alfa 2mg hya-qvfc HCPCS J9334 | not published | not published | $29.82 – $62.23 | 10 |
| Inj eflapegrastim-xnst 0.1mg HCPCS J1449 | not published | not published | $23.55 – $4,947.53 | 13 |
| Inj., emapalumab-lzsg, 1 mg HCPCS J9210 | not published | not published | $330.00 – $1,115.20 | 11 |
| Inj., emicizumab-kxwh 0.5 mg HCPCS J7170 | not published | not published | $47.31 – $31,569.19 | 14 |
| Inj epidural sgl cerv-thor without img CPT 62320 | $1,879.20 | $4,698.00 | $638.70 – $3,652.05 | 15 |
| Inj epidural sgl lumb-sacral without img CPT 62322 | $1,879.20 | $4,698.00 | $638.70 – $4,576.02 | 15 |
| Inj, epinephrine (belcher) HCPCS J0173 | not published | not published | $1.67 – $2.86 | 3 |
| Inj., eravacycline, 1 mg HCPCS J0122 | not published | not published | $1.09 – $583.61 | 14 |
| Inj, erzofri, 1 mg HCPCS J2428 | not published | not published | $14.20 – $26.27 | 8 |
| Inj, etelcalcetide, 0.1 mg HCPCS J0606 | not published | not published | $2.25 – $92.59 | 14 |
| Inj, eteplirsen, 10 mg HCPCS J1428 | not published | not published | $164.16 – $510.73 | 10 |
| Inj, evinacumab-dgnb, 5mg HCPCS J1305 | not published | not published | $164.39 – $6,558.55 | 13 |
| Inj., evomela, 1 mg HCPCS J9246 | not published | not published | $13.55 – $6,558.55 | 14 |
| Inj, exagamglogene autotem HCPCS J3392 | not published | not published | $2,285,360.00 – $5,247,000.00 | 9 |
| Inj, factor x, (human), 1iu HCPCS J7175 | not published | not published | $8.20 – $31,569.19 | 14 |
| Inj, faricimab-svoa, 0.1mg HCPCS J2777 | not published | not published | $31.34 – $1,836.40 | 13 |
| Inj. fe derisomaltose 10 mg HCPCS J1437 | not published | not published | $18.59 – $583.61 | 13 |
| Inj fensolvi 0.25 mg HCPCS J1951 | not published | not published | $126.00 – $1,241.89 | 13 |
| Inj ferric pyrophosphate cit HCPCS J1443 | not published | not published | $0.06 – $0.18 | 2 |
| Inj., fibryga, 1 mg HCPCS J7177 | not published | not published | $0.99 – $1,836.40 | 14 |
| Inj fluphenazine hcl 1.25 mg HCPCS J2679 | not published | not published | $10.77 – $45.85 | 3 |
| Inj, focinvez, 1mg HCPCS J1434 | not published | not published | $2.50 – $7.07 | 9 |
| Inj for ext venography CPT 36005 | $280.40 | $701.00 | $474.53 – $703.00 | 5 |
| Inj for mammo ductogram CPT 19030 | $509.60 | $1,274.00 | $226.14 – $335.03 | 5 |
| Inj, fosaprepitant (teva) HCPCS J1456 | not published | not published | $0.04 – $2.04 | 10 |
| Inj fosnetupitant, palonoset HCPCS J1454 | not published | not published | $268.39 – $1,757.09 | 14 |
| Inj., fremanezumab-vfrm 1 mg HCPCS J3031 | not published | not published | $1.67 – $5.68 | 4 |
| Inj, fulvestrant (fresenius) HCPCS J9394 | not published | not published | $11.03 – $174.78 | 13 |
| Inj, fulvestrant (teva) HCPCS J9393 | not published | not published | $19.08 – $75.55 | 10 |
| Inj, ganciclovir (exela) HCPCS J1574 | not published | not published | $71.40 – $303.96 | 2 |
| Inj gemcitabine hcl (accord) HCPCS J9196 | not published | not published | $7.00 – $174.78 | 8 |
| Inj givosiran 0.5 mg HCPCS J0223 | not published | not published | $101.05 – $269.90 | 11 |
| Inj glofitamab gxbm, 2.5 mg HCPCS J9286 | not published | not published | $2,435.95 – $6,558.55 | 13 |
| Inj glycopyrrolate fres kabi HCPCS J1598 | not published | not published | $2.83 – $12.03 | 3 |
| Inj golodirsen 10 mg HCPCS J1429 | not published | not published | $149.45 – $420.04 | 4 |
| Inj, granisetron, xr, 0.1 mg HCPCS J1627 | not published | not published | $3.80 – $9.65 | 10 |
| Inj., guselkumab, 1 mg HCPCS J1628 | not published | not published | $66.27 – $10,101.67 | 14 |
| Inj., haegarda 10 units HCPCS J0599 | not published | not published | $16.62 – $70.75 | 4 |
| Inj, hemgenix, per tx dose HCPCS J1411 | not published | not published | $3,617,621.00 – $8,347,500.00 | 9 |
| Inj heparin, pfizer, 1000u HCPCS J1643 | not published | not published | $3.08 – $7.33 | 3 |
| Inj. herceptin hylecta, 10mg HCPCS J9356 | not published | not published | $58.15 – $4,947.53 | 14 |
| Inj, hercessi, 10 mg HCPCS Q5146 | not published | not published | $37.11 – $125.94 | 8 |
| Inj herzuma 10 mg HCPCS Q5113 | not published | not published | $54.90 – $4,947.53 | 14 |
| Inj hrt cath w/s&i nonsel p-art angrp CPT 93568 | $320.00 | $800.00 | $226.14 – $335.03 | 5 |
| Inj hrt cath w/s&i sel hrt ang CPT 93563 | $3,643.60 | $9,109.00 | $226.14 – $335.03 | 5 |
| Inj hrt cath w/s&i sel hrt art CPT 93564 | $2,247.20 | $5,618.00 | $226.14 – $335.03 | 5 |
| Inj hrt cath w/s&i sel left vent CPT 93565 | $1,752.80 | $4,382.00 | $226.14 – $335.03 | 5 |
| Inj hrt cath w/s&i sel right vent CPT 93566 | $1,752.80 | $4,382.00 | $226.14 – $335.03 | 5 |
| Inj human fibrinogen con nos HCPCS J7178 | not published | not published | $1.30 – $2,912.99 | 14 |
| Inj hydroxocobalamin IV 25mg HCPCS J3424 | not published | not published | $4.53 – $4,622.13 | 10 |
| Inj hydroxyprogst capoat nos HCPCS J1729 | not published | not published | $14.16 – $92.59 | 9 |
| Inj., ibalizumab-uiyk, 10 mg HCPCS J1746 | not published | not published | $69.53 – $6,558.55 | 14 |
| Inj, idacio, 1 mg HCPCS Q5144 | not published | not published | $21.03 – $32.91 | 2 |
| Inj imip 4 cilas 4 releb 2mg HCPCS J0742 | not published | not published | $2.27 – $176.49 | 11 |
| Inj, imm glob bivigam, 500mg HCPCS J1556 | not published | not published | $67.65 – $397.61 | 13 |
| Inj, immphentiv, 20 mcg HCPCS J2373 | not published | not published | $0.20 – $0.83 | 3 |
| Inj. inebilizumab-cdon, 1 mg HCPCS J1823 | not published | not published | $435.46 – $898.42 | 10 |
| Inj/inf neurolyt sbst spinal canal lesion 62282 CPT 62282 | $2,526.00 | $6,315.00 | $638.70 – $4,576.02 | 15 |
| Inj. infugem, 100 mg HCPCS J9198 | not published | not published | $36.25 – $251.64 | 9 |
| Inj intralesional <= 7 lsn(s) CPT 11900 | $526.40 | $1,316.00 | $122.10 – $1,038.03 | 15 |
| Inj intralesional > 7 lsns CPT 11901 | not published | not published | $122.10 – $1,038.03 | 15 |
| Inj, invega hafyera/trinza HCPCS J2427 | not published | not published | $11.28 – $10,101.67 | 13 |
| Inj ivig privigen 500 mg HCPCS J1459 | not published | not published | $43.80 – $1,836.40 | 14 |
| Inj, ixinity, 1 i.u HCPCS J7213 | not published | not published | $1.55 – $6,558.55 | 13 |
| Inj. jivi 1 iu HCPCS J7208 | not published | not published | $2.20 – $6,558.55 | 14 |
| Inj, kovaltry, 1 i.u HCPCS J7211 | not published | not published | $1.32 – $6,558.55 | 13 |
| Inj labetalol hcl hikma, 5mg HCPCS J1921 | not published | not published | $1.92 – $4.09 | 3 |
| Inj., lanadelumab-flyo, 1 mg HCPCS J0593 | not published | not published | $85.11 – $239.87 | 10 |
| Inj, lanreotide, (cipla) 1mg HCPCS J1932 | not published | not published | $31.55 – $6,558.55 | 13 |
| Inj, lecanemab-irmb, 1 mg HCPCS J0174 | not published | not published | $1.21 – $2.42 | 10 |
| Inj lefamulin 1 mg HCPCS J0691 | not published | not published | $0.65 – $1.83 | 4 |
| Inj, lenacapavir, 1 mg HCPCS J1961 | not published | not published | $19.73 – $6,558.55 | 13 |
| Inj levocarnitine per 1 gm HCPCS J1955 | not published | not published | $48.35 – $152.36 | 2 |
| Inj levoleucovorin nos 0.5mg HCPCS J0641 | not published | not published | $0.02 – $174.78 | 9 |
| Inj, levothyroxine, freskabi HCPCS J0651 | $16.56 | $41.39 | $2.39 – $92.59 | 13 |
| Inj, levothyroxine, hikma HCPCS J0652 | not published | not published | $5.21 – $92.59 | 10 |
| Inj, lidocaine w epinephrine HCPCS J2004 | $15.06 | $37.65 | not published | 0 |
| Inj, linezolid (hospira) HCPCS J2021 | not published | not published | $12.91 – $32.10 | 3 |
| Inj, lovotibeglogene autotem HCPCS J3394 | not published | not published | $3,180,473.76 – $7,393,500.00 | 9 |
| Inj. lumasiran, 0.5 mg HCPCS J0224 | not published | not published | $286.64 – $594.15 | 10 |
| Inj., lumoxiti, 0.01 mg HCPCS J9313 | not published | not published | $21.05 – $6,558.55 | 14 |
| Inj luxturna 1 billion vec g HCPCS J3398 | not published | not published | $3,008.69 – $7,281.23 | 10 |
| Inj lwr xtr fscl pln blk uni w/wo image CPT 64473 | not published | not published | $325.05 – $481.55 | 5 |
| Inj marstacim-hncq, 0.5 mg HCPCS J7172 | not published | not published | $49.19 – $91.00 | 8 |
| Inj. meloxicam 1 mg HCPCS J1738 | not published | not published | $8.22 – $92.59 | 6 |
| Inj melpha hydroch nos 50 mg HCPCS J9245 | not published | not published | $118.25 – $6,558.55 | 14 |
| Inj, melphalan (apotex) 1 mg HCPCS J9249 | not published | not published | $63.48 – $1,918.00 | 12 |
| Inj, melphalan flufenami 1mg HCPCS J9247 | not published | not published | $805.60 – $2,887.62 | 4 |
| Inj melphalan (hepzato) 1 mg HCPCS J9248 | not published | not published | $696.42 – $1,560.38 | 10 |
| Inj mepivacaine hcl/10 ml HCPCS J0670 | $19.98 | $49.95 | not published | 0 |
| Inj, meropenem (b. braun) HCPCS J2184 | not published | not published | $3.38 – $3.38 | 1 |
| Inj., meropenem, vaborbactam HCPCS J2186 | not published | not published | $1.87 – $176.49 | 14 |
| Inj meropenem (wg crit care) HCPCS J2183 | not published | not published | $2.31 – $9.86 | 3 |
| Inj metaraminol bitartrate HCPCS J0380 | not published | not published | $1.16 – $6.79 | 3 |
| Inj, micafungin (par pharm) HCPCS J2247 | $0.81 | $2.01 | $0.44 – $0.54 | 3 |
| Inj, mirikizumab-mrkz, 1 mg HCPCS J2267 | not published | not published | $31.27 – $6,558.55 | 13 |
A missing value means the hospital did not publish that price — it never means the price is zero. Real bills can add facility fees, supplies and professional fees; see our methodology.